An Innovative Partnership: Cleveland Clinic and IBM
Cleveland Clinic and IBM have entered into a 10-year partnership to establish the Discovery Accelerator — a joint center that utilizes Cleveland Clinic’s research and clinical expertise and IBM’s global leadership in computing technologies.
The goal of the partnership is to advance the pace of discovery in healthcare and life sciences by using high-performance computing — including the hybrid cloud, artificial intelligence and quantum computing technologies.
This collaboration is anticipated to create a robust research and clinical framework that will allow big data medical research in responsible, privacy preserving ways. This could lead to discoveries for patient care and new approaches to public health threats such as the COVID-19 pandemic.
IBM plans to install its first private sector, on-premises Quantum System One on Cleveland Clinic’s main campus. Quantum computing has the potential to put revolutionary problem-solving abilities into the hands of scientists and healthcare providers. Learn more about IBM’s work in accelerated discovery.
The Discovery Accelerator will enhance research in the new Global Center for Pathogen & Human Health Research in the fields of genomics, population health, clinical applications and drug discovery.
“Through this innovative collaboration, we have a unique opportunity to bring the future to life. These new computing technologies can help revolutionize discovery in the life sciences. The Discovery Accelerator will enable our renowned teams to build a forward-looking digital infrastructure and help transform medicine, while training the workforce of the future and potentially growing our economy.” - Tom Mihaljevic, MD, CEO and President of Cleveland Clinic (pictured left)
“Our new collaboration with Cleveland Clinic will combine their world-renowned expertise in healthcare and life sciences with IBM’s next-generation technologies to make scientific discovery faster, and the scope of that discovery larger than ever.” - Arvind Krishna, Chairman and Chief Executive Officer of IBM (pictured right)
Focused ResearchResearch in the Discovery Accelerator will focus across a variety of workstreams, including:
Digital technologies and artificial intelligence
Artificial intelligence will be used to generate actionable biomedical knowledge across the continuum of biomedical research and human health.
High-performance computing and hybrid cloud
Researchers use this technology to advance their workloads into the cloud and access cases including personalized medicine and other large-scale, high-intensity data computational needs.
Using quantum mechanics, new computing machines can process information in new ways, promising breakthroughs in a wide range of fields. The Discovery Accelerator uses quantum computing to answer research questions previously limited by classical computers.
Education and outreach
Educating the workforce of the future is critical to the Discovery Accelerator’s success. Educational sessions will be available to Cleveland Clinic and IBM partners — and community stakeholders — on hybrid cloud, artificial intelligence programming and quantum computing.